NASDAQ · Biotechnology

ACIU (ACIU) Stock

$2.31 +0.22% NASDAQ: ACIU Healthcare

Valuation

MetricValue
Price$2.31
Market Cap$234.59M
P/E Ratio-4.04
P/B Ratio6.40
P/S Ratio60.35
EPS (TTM)$-0.70
52-Week High$4.00
52-Week Low$1.51
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-155.56%
ROA-45.45%
ROCE-153.33%
Gross Margin-1700.00%
Operating Margin-1725.00%
Net Margin-17.89%
Debt/Equity0.14
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$4.0M$15.0M$27.0M$4.0M
Operating Profit$-79.0M$-71.0M$-54.0M$-52.0M$-69.0M
Net Profit$-73.0M$-71.0M$-54.0M$-51.0M$-70.0M
EPS$-0.97$-0.85$-0.64$-0.51$-0.70
Op Margin—-1800.4%-362.3%-191.8%-1927.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$261.0M$186.0M$183.0M$231.0M$154.0M
Total Liabilities$29.0M$17.0M$22.0M$119.0M$109.0M
Cash$82.0M$32.0M$78.0M$36.0M$27.0M
Borrowings$3.0M$3.0M$3.0M$5.0M$5.0M

Latest News

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026 GlobeNewswire · Jul 7, 2026 AC Immune Says Antibody Responses Detected in Phase 1b/2 Trial of ACI-24 in Alzheimer's Disease MT Newswires · Jun 30, 2026 AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease GlobeNewswire · Jun 30, 2026 ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last? Zacks · Jun 29, 2026 June 2026 Penny Stocks To Watch For Potential Growth Simply Wall St. · Jun 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-66.0M$-74.0M$-60.0M$66.0M$-66.0M
Investing Cash Flow$-56.0M$23.0M$65.0M$-106.0M$60.0M
Financing Cash Flow$0$-1.0M$0$-1.0M$0
Net Cash Flow$-79.0M$-51.0M$47.0M$-42.0M$-5.0M
Free Cash Flow$-68.0M$-75.0M$-61.0M$65.0M$-67.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-31.38%
Quick Ratio0.87
Interest Coverage—
Return 1Y-6.58%
Return 3Y-21.72%
Return 5Y-69.20%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALDX $1.60 +3.23% -2.77 $96.51M 0.00%
AMRNAmarin Corporation plc $14.58 +0.80% -9.00 $301.45M 0.00%
ANNX $5.37 +0.75% -3.71 $879.83M 0.00%
ANRO $28.67 +0.70% -6.29 $1.01B 0.00%
CLLSCellectis S.A. $2.81 -2.26% -4.14 $282.17M 0.00%

About ACIU

ACIU is led by CEO Andrea Pfeifer, employs 133 people, headquartered in CH, publicly traded since 2016.

ACIU stock trades at $2.31 with a market capitalization of $234.59M. The stock is valued at a price-to-earnings (P/E) ratio of -4.04, price-to-book of 6.40, price-to-sales of 60.35. Over the past 52 weeks the stock has ranged between $1.51 and $4.00, and currently trades 42.3% below its 52-week high.

On profitability, ACIU generates a return on equity (ROE) of -155.56%, return on capital employed of -153.33%, an operating margin of -1725.00%, a net profit margin of -17.89%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides